-
-
-
-
-
-
-
Natera (NTRA) PT Raised to $270 at BTIG
-
-
-
-
-
-
-
Natera (NTRA) Announces Collaboration with Diakonos Oncology for Signatera in Refractory Melanoma
-
-
-
-
-
-
-
Natera (NTRA) PT Lowered to $250 at BTIG
-
-
-
-
-
-
-
Natera (NTRA) PT Lowered to $250 at Morgan Stanley
-
-
-
-
-
-
-
Natera publishes validation study for colorectal cancer test
-
-
-
-
-
-
-
Natera publishes colorectal cancer study results in JAMA Oncology
-
-
-
-
-
-
-
Natera acquires Foresight Diagnostics for up to $450 million
-
434,571 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

